Annual SGA
$13.24 M
+$3.36 M+33.98%
December 31, 2023
Summary
- As of February 10, 2025, ASLN annual SGA is $13.24 million, with the most recent change of +$3.36 million (+33.98%) on December 31, 2023.
- During the last 3 years, ASLN annual SGA has risen by +$6.07 million (+84.68%).
Performance
ASLN SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly SGA
$3.40 M
+$150.40 K+4.63%
March 31, 2024
Summary
- As of February 10, 2025, ASLN quarterly SGA is $3.40 million, with the most recent change of +$150.40 thousand (+4.63%) on March 31, 2024.
- Over the past year, ASLN quarterly SGA has dropped by -$651.50 thousand (-16.10%).
Performance
ASLN Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$1.26 B
-$33.49 M-2.73%
March 31, 2024
Summary
- As of February 10, 2025, ASLN TTM SGA is -$1.26 billion, with the most recent change of -$33.49 million (-2.73%) on March 31, 2024.
- Over the past year, ASLN TTM SGA has dropped by -$1.27 billion (-11163.03%).
Performance
ASLN TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ASLN Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.0% | -16.1% | -10000.0% |
| 3 y3 years | +84.7% | -10.4% | -10000.0% |
| 5 y5 years | +25.9% | -10.4% | -10000.0% |
ASLN Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | -25.4% | -16.1% | -36.0% | +47.7% | at low |
| 5 y | 5-year | at high | -45.9% | -16.1% | -70.6% | +165.8% | at low |
| alltime | all time | at high | -78.7% | -16.1% | -70.6% | +2513.9% | at low |
ASLAN Pharmaceuticals Limited Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $3.40 M(+4.6%) | $12.59 M(-4.9%) |
| Dec 2023 | $13.24 M(+34.0%) | $3.25 M(+2.1%) | $13.24 M(+4.2%) |
| Sep 2023 | - | $3.18 M(+14.9%) | $12.70 M(+7.3%) |
| Jun 2023 | - | $2.77 M(-31.6%) | $11.84 M(+3.9%) |
| Mar 2023 | - | $4.05 M(+49.5%) | $11.39 M(+15.3%) |
| Dec 2022 | $9.88 M(-16.4%) | $2.71 M(+16.8%) | $9.88 M(+5.7%) |
| Sep 2022 | - | $2.32 M(-0.0%) | $9.35 M(-4.6%) |
| Jun 2022 | - | $2.32 M(-8.5%) | $9.80 M(-13.0%) |
| Mar 2022 | - | $2.54 M(+16.7%) | $11.26 M(-4.8%) |
| Dec 2021 | $11.83 M(+64.9%) | - | - |
| Dec 2021 | - | $2.17 M(-21.5%) | $11.83 M(-6.8%) |
| Sep 2021 | - | $2.77 M(-26.9%) | $12.70 M(+12.6%) |
| Jun 2021 | - | $3.79 M(+22.0%) | $11.27 M(+21.5%) |
| Mar 2021 | - | $3.11 M(+2.4%) | $9.28 M(+29.4%) |
| Dec 2020 | $7.17 M(-15.8%) | $3.03 M(+125.1%) | $7.17 M(-3.0%) |
| Sep 2020 | - | $1.35 M(-24.8%) | $7.39 M(+3.3%) |
| Jun 2020 | - | $1.79 M(+79.5%) | $7.16 M(-1.3%) |
| Mar 2020 | - | $997.50 K(-69.4%) | $7.25 M(-14.8%) |
| Dec 2019 | $8.51 M | - | - |
| Dec 2019 | - | $3.26 M(+193.1%) | $8.51 M(+19.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $1.11 M(-41.0%) | $7.15 M(-18.7%) |
| Jun 2019 | - | $1.89 M(-16.4%) | $8.80 M(-11.8%) |
| Mar 2019 | - | $2.26 M(+18.7%) | $9.98 M(-9.5%) |
| Dec 2018 | $10.51 M(+20.0%) | - | - |
| Dec 2018 | - | $1.90 M(-31.0%) | $11.02 M(-6.7%) |
| Sep 2018 | - | $2.76 M(-10.1%) | $11.81 M(+4.7%) |
| Jun 2018 | - | $3.06 M(-7.1%) | $11.28 M(+11.3%) |
| Mar 2018 | - | $3.30 M(+22.4%) | $10.14 M(+14.4%) |
| Dec 2017 | $8.76 M(+25.9%) | - | - |
| Dec 2017 | - | $2.70 M(+21.0%) | $8.86 M(+5.6%) |
| Sep 2017 | - | $2.23 M(+16.2%) | $8.39 M(+3.7%) |
| Jun 2017 | - | $1.92 M(-5.0%) | $8.09 M(+9.4%) |
| Mar 2017 | - | $2.02 M(-9.2%) | $7.39 M(+7.6%) |
| Dec 2016 | $6.96 M(+5.2%) | - | - |
| Dec 2016 | - | $2.22 M(+15.1%) | $6.87 M(+47.8%) |
| Sep 2016 | - | $1.93 M(+58.2%) | $4.65 M(+71.1%) |
| Jun 2016 | - | $1.22 M(-18.4%) | $2.72 M(+81.6%) |
| Mar 2016 | - | $1.50 M | $1.50 M |
| Dec 2015 | $6.61 M(+134.9%) | - | - |
| Dec 2014 | $2.82 M | - | - |
FAQ
- What is ASLAN Pharmaceuticals Limited annual SGA?
- What is the all time high annual SGA for ASLAN Pharmaceuticals Limited?
- What is ASLAN Pharmaceuticals Limited annual SGA year-on-year change?
- What is ASLAN Pharmaceuticals Limited quarterly SGA?
- What is the all time high quarterly SGA for ASLAN Pharmaceuticals Limited?
- What is ASLAN Pharmaceuticals Limited quarterly SGA year-on-year change?
- What is ASLAN Pharmaceuticals Limited TTM SGA?
- What is the all time high TTM SGA for ASLAN Pharmaceuticals Limited?
- What is ASLAN Pharmaceuticals Limited TTM SGA year-on-year change?
What is ASLAN Pharmaceuticals Limited annual SGA?
The current annual SGA of ASLN is $13.24 M
What is the all time high annual SGA for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited all-time high annual SGA is $13.24 M
What is ASLAN Pharmaceuticals Limited annual SGA year-on-year change?
Over the past year, ASLN annual SGA has changed by +$3.36 M (+33.98%)
What is ASLAN Pharmaceuticals Limited quarterly SGA?
The current quarterly SGA of ASLN is $3.40 M
What is the all time high quarterly SGA for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited all-time high quarterly SGA is $4.05 M
What is ASLAN Pharmaceuticals Limited quarterly SGA year-on-year change?
Over the past year, ASLN quarterly SGA has changed by -$651.50 K (-16.10%)
What is ASLAN Pharmaceuticals Limited TTM SGA?
The current TTM SGA of ASLN is -$1.26 B
What is the all time high TTM SGA for ASLAN Pharmaceuticals Limited?
ASLAN Pharmaceuticals Limited all-time high TTM SGA is -$48.22 M
What is ASLAN Pharmaceuticals Limited TTM SGA year-on-year change?
Over the past year, ASLN TTM SGA has changed by -$1.27 B (-11163.03%)